Research peptide
SLU-PP-322
5 mg

Select size
$52.50CAD
Volume pricing
- Buy 2Save 5%$99.75 ($49.88 each)
- Buy 3Save 10%$141.75 ($47.25 each)
Applies to the total quantity in your cart.
- Presentation
- 5 mg
- Container
- Sealed glass vial
- Batch reference
- Printed on every unit
- Documentation
- Batch-specific COA on request
- Research use
- For Research Use Only
Description
SLU-PP-322 is an investigational small-molecule metabolic research compound associated with the estrogen-related receptor (ERR) family, a group of nuclear receptors involved in mitochondrial metabolism, oxidative capacity, and exercise-responsive gene regulation. It is being investigated as a molecular tool for studying how ERR signaling influences cellular energy utilization and metabolic adaptation.
Research surrounding the closely related SLU-PP-332 has demonstrated activation of ERRα/β/γ, with particularly strong activity at ERRα, and has shown increased mitochondrial respiration and oxidative muscle characteristics in experimental models. Animal studies have also investigated effects on fatty-acid oxidation, energy expenditure, metabolic function, and exercise endurance.
The scientific interest in this class of compounds comes from their ability to influence transcriptional programs associated with aerobic metabolism and mitochondrial function. Current research is focused primarily on preclinical models, and human safety, pharmacokinetics, and efficacy should not be inferred from the animal findings. A 2026 review likewise describes pan-ERR agonists as promising but emphasizes the need for clinical studies to establish their relevance in humans.
Key Research Areas
- ERRα / ERRβ / ERRγ signaling
- Mitochondrial metabolism
- Fatty-acid oxidation
- Skeletal-muscle oxidative metabolism
- Energy expenditure and metabolic adaptation
- Exercise-mimetic research
- Endurance and muscle physiology
- Metabolic syndrome and body-composition models
- Mitochondrial and cellular-aging research
Why SLU-PP-322?
The ERR pathway provides researchers with a distinct approach to studying metabolic adaptation at the nuclear-receptor and gene-expression level. Rather than acting as a conventional peptide hormone or growth factor, ERR agonists are being investigated for their ability to influence transcriptional programs governing mitochondrial activity and oxidative metabolism.
At Kinetus Biolabs, SLU-PP-322 is positioned as an investigational small-molecule ERR-pathway research compound for researchers studying mitochondrial biology, metabolic signaling, skeletal-muscle physiology, and exercise-responsive cellular pathways.
Kinetus Biolabs | Precision Science. Peak Potential.
Research Use Only — Not for Human Consumption.





